- Home
- MDT
MDT
Medtronic plc.
as 01-17-2025 4:00pm EST
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
| Founded: | 1949 | Country: | Ireland |
| Employees: | N/A | City: | GALWAY |
| Market Cap: | 111.8B | IPO Year: | N/A |
| Target Price: | $93.67 | AVG Volume (30 days): | 7.3M |
| Analyst Decision: | Hold | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.27 | EPS Growth: | 6.04 |
| 52 Week Low/High: | $75.96 - $92.68 | Next Earning Date: | 02-18-2025 |
| Revenue: | $32,996,000,000 | Revenue Growth: | 3.25% |
| Revenue Growth (this year): | 4.63% | Revenue Growth (next year): | 4.73% |
Stock Insider Trading Activity of Medtronic plc. (MDT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wall Brett A. | MDT | EVP & Pres Neuroscience | Jan 8 '25 | Sell | $80.41 | 9,850 | $792,038.50 | 43,708 |
Latest Medtronic plc. News
MDT Breaking Stock News: Dive into MDT Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Medtronic plc (MDT): Strong Revenue Growth and AI-Driven Innovations Transforming Spine Surgery and Medical Therapies
Zacks
5 days ago
BLS Data Shows Slowdown in Core CPI: Time to Buy MDT Stock Now?
Zacks
5 days ago
Here's Why Medtronic (MDT) Gained But Lagged the Market Today
MT Newswires
7 days ago
Medtronic Says Centers for Medicare & Medicaid Services Opening National Coverage Analysis on Renal Denervation
MedTech Dive
7 days ago
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’
MedTech Dive
7 days ago
CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices
PR Newswire
7 days ago
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
Medical Device Network
8 days ago
Medtronic nets CE mark for Parkinson’s adaptive deep brain stimulation system
Compare MDT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDT Medtronic plc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.